These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9537420)

  • 21. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
    Galbiati F; Engelman JA; Volonte D; Zhang XL; Minetti C; Li M; Hou H; Kneitz B; Edelmann W; Lisanti MP
    J Biol Chem; 2001 Jun; 276(24):21425-33. PubMed ID: 11259414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two novel CAV3 gene mutations in Japanese families.
    Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
    Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localization of the human caveolin-3 gene to the D3S18/D3S4163/D3S4539 locus (3p25), in close proximity to the human oxytocin receptor gene. Identification of the caveolin-3 gene as a candidate for deletion in 3p-syndrome.
    Sotgia F; Minetti C; Lisanti MP
    FEBS Lett; 1999 Jun; 452(3):177-80. PubMed ID: 10386585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity.
    Sunada Y; Ohi H; Hase A; Ohi H; Hosono T; Arata S; Higuchi S; Matsumura K; Shimizu T
    Hum Mol Genet; 2001 Feb; 10(3):173-8. PubMed ID: 11159934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.
    Hayashi YK; Matsuda C; Ogawa M; Goto K; Tominaga K; Mitsuhashi S; Park YE; Nonaka I; Hino-Fukuyo N; Haginoya K; Sugano H; Nishino I
    J Clin Invest; 2009 Sep; 119(9):2623-33. PubMed ID: 19726876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms.
    Bushby KM
    Hum Mol Genet; 1999; 8(10):1875-82. PubMed ID: 10469840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
    Volonte D; Peoples AJ; Galbiati F
    Mol Biol Cell; 2003 Oct; 14(10):4075-88. PubMed ID: 14517320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and muscle pathology in a series of caveolinopathy patients.
    Fulizio L; Nascimbeni AC; Fanin M; Piluso G; Politano L; Nigro V; Angelini C
    Hum Mutat; 2005 Jan; 25(1):82-9. PubMed ID: 15580566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the caveolin-3 gene: When are they pathogenic?
    de Paula F; Vainzof M; Bernardino AL; McNally E; Kunkel LM; Zatz M
    Am J Med Genet; 2001 Apr; 99(4):303-7. PubMed ID: 11251997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confirmation of genetic heterogeneity in limb-girdle muscular dystrophy: linkage of an autosomal dominant form to chromosome 5q.
    Speer MC; Yamaoka LH; Gilchrist JH; Gaskell CP; Stajich JM; Vance JM; Kazantsev A; Lastra AA; Haynes CS; Beckmann JS
    Am J Hum Genet; 1992 Jun; 50(6):1211-7. PubMed ID: 1598902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic behavior of caveolin-3 R26Q, a mutant associated with hyperCKemia, distal myopathy, and rippling muscle disease.
    Sotgia F; Woodman SE; Bonuccelli G; Capozza F; Minetti C; Scherer PE; Lisanti MP
    Am J Physiol Cell Physiol; 2003 Nov; 285(5):C1150-60. PubMed ID: 12839838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A common missense mutation in the adhalin gene in three unrelated Brazilian families with a relatively mild form of autosomal recessive limb-girdle muscular dystrophy.
    Bueno MR; Moreira ES; Vainzof M; Chamberlain J; Marie SK; Pereira L; Akiyama J; Roberds SL; Campbell KP; Zatz M
    Hum Mol Genet; 1995 Jul; 4(7):1163-7. PubMed ID: 8528203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy.
    Hayashi T; Arimura T; Ueda K; Shibata H; Hohda S; Takahashi M; Hori H; Koga Y; Oka N; Imaizumi T; Yasunami M; Kimura A
    Biochem Biophys Res Commun; 2004 Jan; 313(1):178-84. PubMed ID: 14672715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy.
    Speer MC; Gilchrist JM; Chutkow JG; McMichael R; Westbrook CA; Stajich JM; Jorgenson EM; Gaskell PC; Rosi BL; Ramesar R
    Am J Hum Genet; 1995 Dec; 57(6):1371-6. PubMed ID: 8533766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G).
    Vieira NM; Naslavsky MS; Licinio L; Kok F; Schlesinger D; Vainzof M; Sanchez N; Kitajima JP; Gal L; Cavaçana N; Serafini PR; Chuartzman S; Vasquez C; Mimbacas A; Nigro V; Pavanello RC; Schuldiner M; Kunkel LM; Zatz M
    Hum Mol Genet; 2014 Aug; 23(15):4103-10. PubMed ID: 24647604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limb-girdle muscular dystrophy: a follow-up study of 79 patients.
    Mahjneh I; Bushby K; Pizzi A; Bashir R; Marconi G
    Acta Neurol Scand; 1996 Sep; 94(3):177-89. PubMed ID: 8899051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B.
    Bashir R; Britton S; Strachan T; Keers S; Vafiadaki E; Lako M; Richard I; Marchand S; Bourg N; Argov Z; Sadeh M; Mahjneh I; Marconi G; Passos-Bueno MR; Moreira Ede S; Zatz M; Beckmann JS; Bushby K
    Nat Genet; 1998 Sep; 20(1):37-42. PubMed ID: 9731527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy.
    Razani B; Schlegel A; Lisanti MP
    J Cell Sci; 2000 Jun; 113 ( Pt 12)():2103-9. PubMed ID: 10825283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.
    Pradhan BS; Prószyński TJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.